Literature DB >> 24646680

Glomerular filtration rate equations do not accurately predict vancomycin trough concentrations in pediatric patients.

Elizabeth L Alford1, Rebecca F Chhim, Catherine M Crill, M Colleen Hastings, Bettina H Ault, Chasity M Shelton.   

Abstract

BACKGROUND: The Bedside Chronic Kidney Disease in Children (CKiD) equation was developed using data from children with chronic kidney disease. Some institutions are using this equation in all pediatric patients, regardless of renal function, to adjust medications. No data have shown that the Bedside CKiD equation is equivalent or better than the Schwartz equation in estimating glomerular filtration rate (GFR) in pediatric patients with normal renal function.
OBJECTIVE: To compare GFR estimates using the Bedside CKiD and Schwartz equations and determine if either offers sufficient vancomycin dosing guidance in hospitalized pediatric patients.
METHODS: This retrospective review at a single-center, academic, pediatric hospital included patients 2 to 12 years old with a steady-state vancomycin trough collected between January 1, 2010 and December 31, 2011. Patients with acute kidney injury or lacking essential data (e.g., height and serum creatinine), were excluded. An estimated GFR (eGFR) was calculated using the Schwartz and Bedside CKiD equations. Pearson correlations and linear regressions compared the eGFR values and vancomycin troughs.
RESULTS: A total of 50 vancomycin troughs were analyzed. There was a weak relationship between the eGFR and troughs for the Schwartz equation (r (2) = 0.028) and Bedside CKiD equation (r (2) = 0.028). A weak relationship between serum creatinine and troughs was observed (r (2) = 0.132). Limitations include small sample size and retrospective design.
CONCLUSIONS: Neither equation correlates well with vancomycin troughs, suggesting that therapeutic monitoring remains important. Better GFR estimation methods are needed in pediatrics to aid appropriate dosing of renally eliminated medications.

Entities:  

Keywords:  Bedside Chronic Kidney Disease in Children equation; Schwartz equation; pediatrics; serum creatinine–based glomerular filtration rate estimation; vancomycin

Mesh:

Substances:

Year:  2014        PMID: 24646680     DOI: 10.1177/1060028014527908

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

Review 1.  Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.

Authors:  Geisa Cristina da Silva Alves; Samuel Dutra da Silva; Virginia Paula Frade; Danielle Rodrigues; André de Oliveira Baldoni; Whocely Victor de Castro; Cristina Sanches
Journal:  Eur J Clin Pharmacol       Date:  2017-08-04       Impact factor: 2.953

2.  Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients.

Authors:  Piergiorgio Cojutti; Natalia Maximova; Federico Pea
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

3.  A Population Pharmacokinetic Analysis to Study the Effect of Therapeutic Hypothermia on Vancomycin Disposition in Children Resuscitated From Cardiac Arrest.

Authors:  Nicole R Zane; Michael D Reedy; Marc R Gastonguay; Adam S Himebauch; Evan Z Ramsey; Alexis A Topjian; Athena F Zuppa
Journal:  Pediatr Crit Care Med       Date:  2017-07       Impact factor: 3.624

4.  Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients.

Authors:  Vanessa E Millisor; Jessica K Roberts; Yilun Sun; Li Tang; Vinay M Daryani; David Gregornik; Shane J Cross; Deborah Ward; Jennifer L Pauley; Alejandro Molinelli; Rachel C Brennan; Clinton F Stewart
Journal:  Pediatr Nephrol       Date:  2017-06-02       Impact factor: 3.714

5.  Effect of Cystatin C on Vancomycin Clearance Estimation in Critically Ill Children Using a Population Pharmacokinetic Modeling Approach.

Authors:  Kevin J Downes; Nicole R Zane; Athena F Zuppa
Journal:  Ther Drug Monit       Date:  2020-12       Impact factor: 3.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.